Skip to main content
ADCT
NYSE Life Sciences

ADC Therapeutics Extends Cash Runway into 2028, Reports Q1 Revenue Growth

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.15
Mkt Cap
$487.136M
52W Low
$1.225
52W High
$4.98
52W Position info
239% above low
Off High info
17% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ADCT has more than doubled off its 52-week low of $1.225.

Summary

ADC Therapeutics reported its first-quarter 2026 financial results, highlighting net product revenue of $20.0 million, an increase from $17.4 million in the prior year. Critically, the company announced a robust cash position of $231.0 million as of March 31, 2026, which is expected to fund operations at least into 2028. This significant extension of the cash runway provides substantial financial stability and de-risks the company's ability to advance its clinical pipeline. Upcoming catalysts include topline data from the LOTIS-5 Phase 3 trial in the second quarter of 2026, with full data for both LOTIS-5 and LOTIS-7 anticipated by year-end, which could lead to a supplemental Biologics License Application (sBLA) submission. This news is new and material, not previously disclosed in recent SEC filings.

At the time of this announcement, ADCT was trading at $4.15 on NYSE in the Life Sciences sector, with a market capitalization of approximately $487.1M. The 52-week trading range was $1.23 to $4.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADCT - Latest Insights

ADCT
Nov 09, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.29 info
Change: -$0.456 (-26%) info
Market Cap: $182.86M info
ADCT
Nov 09, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.29 info
Change: -$0.290 (-18%) info
Market Cap: $182.86M info
ADCT
Nov 04, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.29 info
Change: -$0.430 (-25%) info
Market Cap: $182.86M info
ADCT
Nov 03, 2026, 5:02 PM EST
Filing Type: S-4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.29 info
Change: -$0.260 (-17%) info
Market Cap: $182.86M info
ADCT
Oct 13, 2026, 6:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.82
Real-time Price: $1.29 info
Change: -$0.530 (-29%) info
Market Cap: $182.86M info